date:Aug 17, 2012
12 months showed that 0% of the curcumin-treated subjects developed T2DM, compared to 16.4% of the placebo-treated group that did.
The Thai researchers, led by Somlak Chuengsamarn, said that additionally, curcumin intervention also improved beta-cell functions, indicated by an increased HOMA-beta and reduced C-peptide.
Adiponectin levels were also significantly increased with curcumin consumption an anti-inflammatory cytokine associated with a lower risk of T22DM. It is the anti-inflammatory